Mobious Genomics Allowed Milestone US Sequencing Patents
Exeter, England. Mobious Genomics Ltd., the UK based bionanotechnology company, announced that it has received formal notice of allowance from the United States Patent Office for broad technology defining patents covering real-time polynucleotide sequencing. The patents outline the application of cellular replication systems to achieve commercially viable ultra high speed sequencing technology.
Relating to methods and devices for real-time monitoring of cellular replication processes in order to achieve ultra high throughput Genomic analysis as well as robust "regenerative" capabilities, the patents cover core elements of Mobious's platform technology. The patents are held my Mobious's patent holding company, Medical Biosystems Ltd.
Organizations
Other news from the department research and development

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Alzheimer's and Parkinson's spurred by same enzyme
That tastes -- sweet? Sour? No, it's definitely calcium! - That tastes -- sweet? Sour? No, it's definitely calcium!
MDS Pharma Services opens its first U.S. central lab
